Belumosudil and Tolvaptan: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Belumosudil
Tolvaptan
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Belumosudil (Rezurock) can block a 'pump' in your body called P-gp that normally helps push certain drugs out. Tolvaptan (Jynarque or Samsca) relies on that pump. When belumosudil slows it down, more tolvaptan can build up in your blood than usual.
With higher tolvaptan levels, you might notice stronger effects like extra thirst, frequent urination, or dehydration. The good news is your care team can handle this. They may adjust your tolvaptan dose or watch you more closely. Please don't stop or change either medicine on your own just talk with your pharmacist or doctor about taking both.
Mechanism: Belumosudil inhibits P-glycoprotein (P-gp)-mediated efflux, reducing clearance of P-gp substrates. Tolvaptan is a P-gp substrate, so concurrent use is expected to increase tolvaptan exposure (higher Cmax/AUC) and amplify its pharmacodynamic and adverse effects.
- Direction: increased tolvaptan exposure (neither drug is a prodrug here)
- Magnitude: in a study, belumosudil raised dabigatran (P-gp substrate) Cmax and AUC ~2-fold; tolvaptan effect not directly quantified
- Evidence: probable; Severity: major; onset unspecified
- Management: avoid coadministration if possible; if unavoidable, reduce tolvaptan dose as needed and monitor closely (fluid/volume status, sodium, thirst, aquaresis).
What happens
Increased P-gp substrate exposure
Interaction Deep Dive
Do not give belumosudil (a P-gp inhibitor) together with a P-gp substrate that has a narrow therapeutic index (NTI), since even small shifts in concentration can produce serious toxicities. When such combined use is unavoidable, reduce the dose of the P-gp substrate as required. A drug interaction study showed that giving belumosudil alongside dabigatran (a P-gp substrate) raised dabigatran's Cmax and AUC by 2-fold1.
Why it happens (mechanism)
Inhibition of P-gp-mediated efflux transport by belumosudil
How to manage this interaction
What your care team may do:
- Prefer to avoid using these two together when possible, since tolvaptan is a narrow-margin drug where small increases matter.
- If both are needed, your tolvaptan dose may be reduced and individualized by your team.
- They may monitor you more closely, watching for signs of too much tolvaptan effect.
What you should do: Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Tell your pharmacist or doctor you are on both, and report increased thirst, heavy urination, dizziness, or signs of dehydration.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In a study evaluating drug interactions, giving belumosudil together with dabigatran (a P-gp substrate) raised the Cmax and AUC of dabigatran by 2-fold 1.
Common questions
Can I take Belumosudil and Tolvaptan together?
Belumosudil can raise tolvaptan levels by blocking the P-gp pump, so your team will likely avoid the combination or lower and monitor your tolvaptan dose. Do not change either medicine yourself; check with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Belumosudil and Tolvaptan interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Belumosudil and Tolvaptan interaction managed?
What your care team may do: Prefer to avoid using these two together when possible, since tolvaptan is a narrow-margin drug where small increases matter. If both are needed, your tolvaptan dose may be reduced and individualized by your team. They may monitor you more closely, watching for signs of too much tolvaptan effect. What you should do: Keep taking both exactly as prescribed unless your pre… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Belumosudil or Tolvaptan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: REZUROCK(R) oral tablets, belumosudil oral tablets. Kadmon Pharmaceuticals LLC (per FDA), Bridgewater, NJ, 2024. DailyMed
Keep reading about Belumosudil
Keep reading about Tolvaptan
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist